<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Jamkas Pharmaceuticals Launches Cost-Effective Third-Party Manufacturing Model for Emerging Pharma Brand</title>
    <link>https://www.taxtmi.com/news?id=58502</link>
    <description>Jamkas Pharmaceuticals offers a cost effective third party manufacturing model enabling emerging and small to medium pharma brands to outsource formulation, production and packaging while relying on ISO and GMP WHO certified facilities with QA/QC at each stage to ensure regulatory compliance, product quality, timely delivery and access to a diverse therapeutic product range.</description>
    <language>en-us</language>
    <pubDate>Sat, 11 Oct 2025 12:01:03 +0530</pubDate>
    <lastBuildDate>Sat, 11 Oct 2025 12:01:03 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=857826" rel="self" type="application/rss+xml"/>
    <item>
      <title>Jamkas Pharmaceuticals Launches Cost-Effective Third-Party Manufacturing Model for Emerging Pharma Brand</title>
      <link>https://www.taxtmi.com/news?id=58502</link>
      <description>Jamkas Pharmaceuticals offers a cost effective third party manufacturing model enabling emerging and small to medium pharma brands to outsource formulation, production and packaging while relying on ISO and GMP WHO certified facilities with QA/QC at each stage to ensure regulatory compliance, product quality, timely delivery and access to a diverse therapeutic product range.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Sat, 11 Oct 2025 12:01:03 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=58502</guid>
    </item>
  </channel>
</rss>